M&A Deal Summary |
|
|---|---|
| Date | 2017-07-03 |
| Target | HealthStrong |
| Sector | Healthcare Services |
| Buyer(s) | Medibank Private |
| Sellers(s) | Mercury Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
Medibank Private Ltd. is a provider of insurance services.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Australia M&A | 2 of 2 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-08 |
McKesson Asia Pacific
Australia McKesson Asia Pacific is a provider of phone- and web-based healthcare services, including telephone triage, health and wellness advice, chronic disease management and mental health services in Australia and New Zealand. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2010 |
| PE ASSETS | 1.0B AUD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Mercury Capital is a private equity group focused on investing in established private businesses operating in Australia and New Zealand. Mercury looks to acquire controlling positions for a variety of situations, including succession plannings, expansion financings, recapitalizations, as well as partnering with existing management or owners to help drive growth. Mercury raised it's debut fund in 2010.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 7 |
| Sector: Healthcare Services M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 1 of 3 |
| Country: Australia M&A | 3 of 5 |
| Year: 2017 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-01 |
Tāmaki Health
Auckland, New Zealand Tāmaki Health is a primary care operator that operates a portfolio of 49 clinics primarily located in “high needs” areas, including 19 Urgent Care Clinics largely across Auckland. Tāmaki Health is based in Auckland, New Zealand. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-25 |
Novotech
Sydney, Australia Novotech is a full-service contract research organization (CRO) that provides biotech and small- to mid-sized pharmaceutical companies. Novotech was founded in 1997 and is headquartered in Sydney, New South Wales. |
Sell | $300M |